Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tcr2 Therapeutics Inc
(NQ:
TCRR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tcr2 Therapeutics Inc
< Previous
1
2
3
4
Next >
Where TCR2 Therapeutics Stands With Analysts
January 06, 2023
Via
Benzinga
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 05, 2023
From
TCR2 Therapeutics
Via
GlobeNewswire
TCR² Therapeutics Announces Pipeline Priorities for 2023
January 05, 2023
From
TCR2 Therapeutics
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
December 16, 2022
During Friday's trading, 293 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
On Wednesday, 200 companies hit new 52-week lows.
Via
Benzinga
TCR2 Therapeutics Shares Jump After Additional Reponses in Ovarian Cancer, Mesothelioma
September 28, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 22, 2022
Thursday's session saw 329 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 15, 2022
On Thursday, 241 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Monday saw 196 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 09, 2022
On Friday, 127 companies set new 52-week lows.
Via
Benzinga
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2022
From
TCR2 Therapeutics
Via
GlobeNewswire
TCR² Therapeutics to Present at the Piper Sandler Healthcare Conference
November 23, 2022
From
TCR2 Therapeutics
Via
GlobeNewswire
Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday
November 21, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 09, 2022
On Wednesday, 283 companies set new 52-week lows.
Via
Benzinga
TCR² Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 08, 2022
From
TCR2 Therapeutics
Via
GlobeNewswire
TCR² Therapeutics Presents Preclinical Data on Functional Activity of Gavo-cel at the Society for Immunotherapy of Cancer
November 07, 2022
From
TCR2 Therapeutics
Via
GlobeNewswire
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2022
From
TCR2 Therapeutics
Via
GlobeNewswire
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2022
From
TCR2 Therapeutics
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 28, 2022
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Via
InvestorPlace
gavo-cel Continues to Demonstrate Clinical Benefit in Solid Tumors with Additional RECIST Reponses in Ovarian Cancer and Mesothelioma
September 28, 2022
From
TCR2 Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 27, 2022
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.
Via
Benzinga
TCR² Therapeutics to Announce Complete Phase 1 Portion of the Gavo-cel Phase 1/2 Clinical Trial for Mesothelin-Expressing Solid Tumors
September 27, 2022
From
TCR2 Therapeutics
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
May 26, 2022
On Thursday, 94 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 19, 2022
On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
March 23, 2022
SVB Leerink cut the price target on TCR2 Therapeutics Inc. (NASDAQ: TCRR) from $7 to $3. TCR2 Therapeutics shares rose 16% to close at $3.19 on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 22, 2022
Gainers Palisade Bio (NASDAQ:PALI) shares rose 34.1% to $1.08 during Tuesday's regular session. Trading volume for this security as of 13:31 EST is 52.4 million, which...
Via
Benzinga
43 Stocks Moving In Tuesday's Mid-Day Session
March 22, 2022
Gainers Forge Global Holdings Inc. (NYSE: FRGE) shares jumped 67.7% to $16.95. True Global Ventures’ portfolio company Forge Global Holdings completed its business...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.